Cellectis Provides Business Update and Reports Financial ResultsĀ for Second Quarter 2022

Go back to Cellectis Provides Business Update and Reports Financial ResultsĀ for Second Quarter 2022

Cellectis (CLLS) Misses Q2 EPS by 29c

August 4, 2022 5:15 PM EDT

Cellectis (NASDAQ: CLLS) reported Q2 EPS of ($0.80), $0.29 worse than the analyst estimate of ($0.51). Revenue for the quarter came in at $14.62 million versus the consensus estimate of $23.46 million.

For earnings history and earnings-related data on Cellectis (CLLS) click here.

... More